Mayo T, Armstrong AW, Kircik L, Silverberg J, Blauvelt A, Esdalie B, Schneider S, Mark T, Gooderham M, Alexis AF. Efficacy and safety of up to two years of tralokinumab treatment in adults of different racial subgroups with moderate-to-severe atopic dermatitis. J of Skin [Internet]. 2022Nov.16 [cited 2024Jul.22];6(6):s74. Available from: https://jofskin.org/index.php/skin/article/view/1831